Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hitoshi Ichikawa

Showing results (61-70 of 170) with videos related to

Pageof 17
Sort By:
Blood|May 10, 2003
Identification of a gene expression signature associated with pediatric AML prognosisTomohito Yagi, Akira Morimoto, Mariko Eguchi, et al.
Journal of Gastroenterology|April 20, 2010
Novel endoscopic activity index is useful for choosing treatment in severe active ulcerative colitis patientsMakoto Naganuma, Hitoshi Ichikawa, Nagamu Inoue, et al.
Oncotarget|February 9, 2011
Src activates Abl to augment Robo1 expression in order to promote tumor cell migrationP Raaj Khusial, Bhaskar Vadla, Harini Krishnan, et al.
The American Journal of Surgical Pathology|December 7, 2018
Novel NTRK3 Fusions in Fibrosarcomas of AdultsFumito Yamazaki, Fumihiko Nakatani, Naofumi Asano, et al.
The American Journal of Surgical Pathology|January 24, 2020
NKX3-1 Is a Useful Immunohistochemical Marker of EWSR1-NFATC2 Sarcoma and Mesenchymal ChondrosarcomaKen-Ichi Yoshida, Isidro Machado, Toru Motoi, et al.
International Journal of Hematology|November 9, 2007
Low frequency of KIT gene mutation in pediatric acute myeloid leukemia with inv(16)(p13q22): a study of the Japanese Childhood AML Cooperative Study GroupAkira Shimada, Hitoshi Ichikawa, Tomohiko Taki, et al.
The American Journal of Surgical Pathology|January 9, 2018
Clarifying the Distinction Between Malignant Peripheral Nerve Sheath Tumor and Dedifferentiated Liposarcoma: A Critical Reappraisal of the Diagnostic Utility of MDM2 and H3K27me3 StatusNaohiro Makise, Masaya Sekimizu, Takashi Kubo, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 28, 2007
Gene expression analysis of soft tissue sarcomas: characterization and reclassification of malignant fibrous histiocytomaRobert Nakayama, Takeshi Nemoto, Hiro Takahashi, et al.
The Journal of Experimental Medicine|February 22, 2012
Lethal myelofibrosis induced by Bmi1-deficient hematopoietic cells unveils a tumor suppressor function of the polycomb group genesHideyuki Oguro, Jin Yuan, Satomi Tanaka, et al.
Journal of Orthopaedic Science : Official Journal of the Japanese Orthopaedic Association|September 17, 2021
Prognostic impact of IDH mutations in chondrosarcomaMakoto Nakagawa, Masaya Sekimizu, Makoto Endo, et al.
Pageof 17

Showing results (61-70 of 170) with videos related to

Sort By:
Pageof 17
Blood|May 10, 2003
Identification of a gene expression signature associated with pediatric AML prognosisTomohito Yagi, Akira Morimoto, Mariko Eguchi, et al.
Journal of Gastroenterology|April 20, 2010
Novel endoscopic activity index is useful for choosing treatment in severe active ulcerative colitis patientsMakoto Naganuma, Hitoshi Ichikawa, Nagamu Inoue, et al.
Oncotarget|February 9, 2011
Src activates Abl to augment Robo1 expression in order to promote tumor cell migrationP Raaj Khusial, Bhaskar Vadla, Harini Krishnan, et al.
The American Journal of Surgical Pathology|December 7, 2018
Novel NTRK3 Fusions in Fibrosarcomas of AdultsFumito Yamazaki, Fumihiko Nakatani, Naofumi Asano, et al.
The American Journal of Surgical Pathology|January 24, 2020
NKX3-1 Is a Useful Immunohistochemical Marker of EWSR1-NFATC2 Sarcoma and Mesenchymal ChondrosarcomaKen-Ichi Yoshida, Isidro Machado, Toru Motoi, et al.
International Journal of Hematology|November 9, 2007
Low frequency of KIT gene mutation in pediatric acute myeloid leukemia with inv(16)(p13q22): a study of the Japanese Childhood AML Cooperative Study GroupAkira Shimada, Hitoshi Ichikawa, Tomohiko Taki, et al.
The American Journal of Surgical Pathology|January 9, 2018
Clarifying the Distinction Between Malignant Peripheral Nerve Sheath Tumor and Dedifferentiated Liposarcoma: A Critical Reappraisal of the Diagnostic Utility of MDM2 and H3K27me3 StatusNaohiro Makise, Masaya Sekimizu, Takashi Kubo, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 28, 2007
Gene expression analysis of soft tissue sarcomas: characterization and reclassification of malignant fibrous histiocytomaRobert Nakayama, Takeshi Nemoto, Hiro Takahashi, et al.
The Journal of Experimental Medicine|February 22, 2012
Lethal myelofibrosis induced by Bmi1-deficient hematopoietic cells unveils a tumor suppressor function of the polycomb group genesHideyuki Oguro, Jin Yuan, Satomi Tanaka, et al.
Journal of Orthopaedic Science : Official Journal of the Japanese Orthopaedic Association|September 17, 2021
Prognostic impact of IDH mutations in chondrosarcomaMakoto Nakagawa, Masaya Sekimizu, Makoto Endo, et al.
Pageof 17